These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28834781)

  • 21. [Russian experience of lacosamide (vimpat) usage in treatment of uncontrolled focal epilepsy].
    Lebedeva AV; Burd SG; Belyaev OV; Vlasov PN; Dorofeeva MY; Ismailov AM; Kissin MY; Kovaleva IY; Koroleva NY; Lipatova LV; Mukhin KY; Solomatin YV; Chervyakov AV; Shikhkerimov RG; Pylaeva OA; Freidkova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9. Vyp. 2):74-81. PubMed ID: 28005051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
    Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy.
    IJff DM; van Veenendaal TM; Majoie HJ; de Louw AJ; Jansen JF; Aldenkamp AP
    Acta Neurol Scand; 2015 Jun; 131(6):347-54. PubMed ID: 25630655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
    Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
    Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical impact of the dose and blood concentration of lacosamide in Japanese pediatric patients with epilepsy: A cohort study.
    Ishikawa N; Eguchi Y; Izumo H; Tateishi Y; Tani H; Kobayashi Y; Okada S
    Epilepsy Behav; 2022 Apr; 129():108614. PubMed ID: 35203014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous lacosamide in clinical practice-Results from an independent registry.
    Lang N; Lange M; Schmitt FC; Bös M; Weber Y; Evers S; Burghaus L; Kellinghaus C; Schubert-Bast S; Bösel J; Lammers T; Sabolek M; van Baalen A; Dziewas R; Kraft A; Ruf S; Stephani U
    Seizure; 2016 Jul; 39():5-9. PubMed ID: 27161669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.
    Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J
    Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial variations in lacosamide serum concentrations in adult patients with epilepsy.
    Zutshi D; Yarraguntla K; Mahulikar A; Seraji-Bozorgzad N; Shah AK; Basha MM
    J Neurol Sci; 2020 May; 412():116742. PubMed ID: 32126366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies - A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center.
    Kurth C; Kockelmann E; Steinhoff BJ
    Seizure; 2017 Feb; 45():47-51. PubMed ID: 27915111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy.
    Villanueva V; Saiz-Diaz R; Toledo M; Piera A; Mauri JA; Rodriguez-Uranga JJ; López-González FJ; Gómez-Ibáñez A; Garcés M; González de la Aleja J; Rodríguez-Osorio X; Palao-Duarte S; Castillo A; Bonet M; Ruiz-Giménez J; Palau J; Arcediano A; Toledo M; Gago A
    Epilepsy Behav; 2016 Dec; 65():25-32. PubMed ID: 27863278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohort.
    McGinnis E; Kessler SK
    Epilepsia; 2016 Sep; 57(9):1416-25. PubMed ID: 27430392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lacosamide in the treatment of patients with epilepsy and intellectual disabilities: A long-term study of 136 patients.
    Böttcher S; Lutz MT; Mayer T
    Epilepsia; 2017 Oct; 58(10):1749-1754. PubMed ID: 28804872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lacosamide and concomitant use of antiepileptic and other medications in a US population - A retrospective cohort study.
    Kalilani L; Lu C; Pierre-Louis B; Gold M
    Epilepsy Behav; 2017 Jul; 72():51-57. PubMed ID: 28575767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study.
    Mo F; Meletti S; Belcastro V; Quadri S; Napolitano M; Bello L; Dainese F; Scarpelli M; Florindo I; Mascia A; Pauletto G; Bruno F; Pellerino A; Giovannini G; Polosa M; Sessa M; Conti Nibali M; Di Gennaro G; Gigli GL; Pisanello A; Cavallieri F; Rudà R
    J Neurooncol; 2022 May; 157(3):551-559. PubMed ID: 35397759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
    Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
    Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lacosamide efficacy and tolerability in clinical practice - Post marketing analysis from a single dedicated epilepsy center.
    Baker MD; Abou-Khalil BW; Arain A; Tummala P; Azar NJ; Haas KF; Sonmezturk HH
    Clin Neurol Neurosurg; 2018 Aug; 171():179-183. PubMed ID: 29929174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures.
    García-Morales I; Delgado RT; Falip M; Campos D; García ME; Gil-Nagel A
    Seizure; 2011 Dec; 20(10):801-4. PubMed ID: 21917484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of lacosamide in children: experience of a tertiary medical care center in Brazil.
    Romão TT; Angelim AIM; Prado HJPD; Goes FV; Pires MEP; Fontana RDS; Pires LC; Fernandes AR; D'Andrea-Meira I
    Arq Neuropsiquiatr; 2022 Nov; 80(11):1090-1096. PubMed ID: 36577407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience of intravenous lacosamide in infants and young children.
    Arkilo D; Gustafson M; Ritter FJ
    Eur J Paediatr Neurol; 2016 Mar; 20(2):212-217. PubMed ID: 26810009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients.
    Parkerson KA; Reinsberger C; Chou SH; Dworetzky BA; Lee JW
    Epilepsy Behav; 2011 Jan; 20(1):48-51. PubMed ID: 21093380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.